Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132034) titled 'Clinical Study of Central Radiofrequency Ablation (SCART) Combined with Toripalimab in Patients with Bulky Solid Tumors Refractory to Standard Therapy' on Sept. 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

Condition: Solid tumors

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-11

Target Sample Size: Experimental Group:32;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=342207

Published by HT Digital Content Services with permiss...